KDM5A-IN-1

CAS No. 1905481-36-8

KDM5A-IN-1( KDM5A-IN-1 | KDM5A IN 1 | KDM5AIN1 | KDM5A inhibitor-1 )

Catalog No. M12988 CAS No. 1905481-36-8

An inhibitor of histone demethylase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 260 Get Quote
50MG 1116 Get Quote
100MG 1566 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    KDM5A-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    An inhibitor of histone demethylase.
  • Description
    An inhibitor of histone demethylase.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Female CD-1 miceDosage:5 mg/kg Administration:Oral administration (Pharmacokinetic study) Result:Moderate clearance (28 mL/min/kg) in mice with good oral bioavailability (F% 34), and showed remarkably low plasma protein binding in mice (40%).
  • Synonyms
    KDM5A-IN-1 | KDM5A IN 1 | KDM5AIN1 | KDM5A inhibitor-1
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    Histone Demethylase
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1905481-36-8
  • Formula Weight
    290.3608
  • Molecular Formula
    C15H22N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(C1CC1)N[C@@H]2CCN(C(C3=CC(C(C)C)=NN3)=O)C2
  • Chemical Name
    Cyclopropanecarboxamide, N-[(3R)-1-[[5-(1-methylethyl)-1H-pyrazol-3-yl]carbonyl]-3-pyrrolidinyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kwong Wah LAI, et al. WO 2016057924 A1 20160414.
molnova catalog
related products
  • KDM5-IN-48

    A potent, selective and orally bioavailable KDM5 inhibitor with biochemical IC50 of 15.1, 4.7 and 65.5 nM for KDM5A, KDM5B and KDM5C, respectively.

  • Tazemetostat hydrobr...

    Tazemetostat hydrobromide is a potent and selective EZH2 inhibitor.

  • EZM0414

    EZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.